With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

The global genomics market is projected to expand by 15-17% by 2029. Key factors driving this growth include the increasing ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

The Bermuda Principles Foundation has announced that its 30th Anniversary Conference, themed “Future-Proofing Global ...

It is great to welcome UAMS to the Caris POA. Their unwavering commitment to excellence perfectly aligns with our commitment to advance biomarker-driven precision oncology,” said James Hamrick, MD, ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance ...

UK Biobank is one of the most ambitious population health research resources in the world. Launched in 2006, it holds in ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance at a resilient ...